|
|
-
|
-
|
|
|
|
|
|
Benzidine
EC / List no:
202-199-1
| CAS no:
92-87-5
|
-
|
-
|
|
|
|
Annex 17; Annex 17 Appendix 1
|
|
|
|
-
|
-
|
|
|
|
Annex 17; Annex 17 Appendix 1
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, zinc salt
EC / List no:
-
| CAS no:
70136-72-0
Sulfonium, [4-[(2-methyl-1-oxo-2-propenyl)oxy]phenyl]diphenyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1), polymer with 2-ethyltricyclo[3.3.1.13,7]dec-2-yl 2-methyl-2-propenoate, 3-hydroxytricyclo[3.3.1.13,7]dec-1-yl 2-methyl-2-propenoate and tetrahydro-2-oxo-3-furanyl 2-methyl-2-propenoate
EC / List no:
-
| CAS no:
911027-69-5
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
Selenourea
EC / List no:
211-129-9
| CAS no:
630-10-4
Residues, zinc refining flue dust wastewater, mercury-selenium
The hot gases obtained by the roasting of raw zinc concentrate are cooled and cleaned from dust by passing through a spray of dilute sulfuric acid and/or water. This acid and/or water is filtered; the solid residue contains most of the volatile components of the concentrates to be roasted.
EC / List no:
309-609-9
| CAS no:
100403-63-2
Selenium
EC / List no:
231-957-4
| CAS no:
7782-49-2
|
-
|
-
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
|
-
|
-
|
|
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
|
-
|
-
|
|
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
|
-
|
-
|
|
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
|
-
|
-
|
|
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
|
-
|
-
|
|
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
SÄUREBRAUN 6230
|
401-220-3
|
-
|
|
|
|
|
|
|
EURESYNTH(R) 5010
|
418-720-2
|
-
|
|
|
|
|
|
|
|
435-240-9
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
